Nicotine Pouch Packaging for Stop-Smoking & NRT Programs
Medical-grade, child-resistant packaging for nicotine replacement therapy (NRT) and stop-smoking programs. Private-label and OEM-ready. Compatible with ZYN, Velo, Pablo, and White Fox formats. Compliant with EU TPD Article 20, FDA guidance, and UK MHRA. Program-ready documentation from day one.
What Makes NRT Packaging Different from Recreational Nicotine Pouches?
Stop-smoking programs and nicotine replacement therapy (NRT) channels — NHS clinics, pharmacy chains, employer wellness programs — do not buy packaging the same way recreational brands do. Recreational buyers prioritize shelf appeal and lifestyle branding. NRT buyers prioritize compliance documentation, clinical aesthetics, and batch traceability. While the industry is shifting from traditional snus to modern nicotine pouches, the packaging requirements for stop-smoking programs remain the same — child-resistant, tamper-evident, and fully documented.
Regulatory Scope Is Broader
Recreational nicotine pouches in the EU need TPD Article 20 compliance. NRT programs need TPD Article 20 plus therapeutic-goods alignment — especially in the UK (MHRA) and Australia (TGA). In the US, NRT-adjacent products often fall under FDA Center for Drug Evaluation and Research (CDER) or CPSC guidance, depending on marketing claims. Our regulatory mapping covers all four jurisdictions before design begins.
mg-Strength Labeling Is Non-Negotiable
NRT programs specify exact nicotine strengths — typically 2 mg, 4 mg, 6 mg, 11 mg, or 20 mg per pouch — and the packaging must display this clearly without implying recreational use. We provide label templates that separate "dose" information from brand imagery, ensuring your product reads as a cessation tool at pharmacy checkout. (Internal data: 11 mg formats show 20% higher click-through rates in B2B procurement platforms, suggesting mid-strength SKUs are a sweet spot for program tenders.)
Documentation Must Be Tender-Ready
A recreational order ships with a CR certificate and an invoice. An NRT tender submission requires ISO 8317 test reports, material safety data sheets (MSDS), batch traceability records, REACH declarations, and sometimes FDA 510(k) alignment letters. We pre-format these bundles by market, so your regulatory team spends days — not months — on paperwork.
Compatible with Leading Formats
All formats are compatible with ZYN, Pablo, Velo, White Fox, and Killa. If you are switching from an existing supplier or white-labeling a Velo-compatible stop-smoking format, send us your current spec sheet and we will confirm drop-in compatibility within 24 hours.
Why Cessation Programs Need Specialized Packaging
My tender was rejected because the packaging did not meet NHS requirements
A missing ISO 8317 CR report or an incorrect MHRA registration format can disqualify your entire tender. One oversight costs 6–12 months and tens of thousands in lost revenue — and you may not even know why until the rejection letter arrives.
My current supplier ships cans and leaves me to figure out compliance docs
Most packaging suppliers treat documentation as an afterthought. They deliver the cans and hand you a generic CR certificate. NHS onboarding, FDA 510(k) alignment, and REACH declarations? That is your problem, not theirs.
Explore custom design optionsI need to launch in the UK and EU but my supplier only understands US FDA
Single-market suppliers force you to manage multiple vendors for multi-region launches. Each vendor uses different specs, different CR tests, and different batch traceability formats — creating audit gaps at the worst possible time.
Regulatory Compliance by Market
Pre-mapped documentation bundles for the four major cessation-program markets.
| Market | Standard | Requirement | Status |
|---|---|---|---|
| 🇺🇸 United States | FDA / CPSC | CR packaging + cessation marketing claims review | Fully supported |
| 🇪🇺 European Union | TPD Article 20 | CR packaging + health warning compliance | Requirements mapped |
| 🇬🇧 United Kingdom | MHRA / UK TPD | Post-Brexit registration + CR compliance | Requirements mapped |
| 🇦🇺 Australia | TGA | Therapeutic goods packaging standards | Requirements identified |
Not sure which market to enter first? Request a free sample pack →
From Regulatory Map to Market Entry in 5 Steps
Compliance-first packaging for clinics, pharmacies, and government programs.
Regulatory Mapping
We identify the exact packaging requirements for your target market — US FDA, EU TPD Article 20, UK MHRA, or AU TGA. No guesswork, no surprises at customs.
Design Direction
Choose between medical-grade aesthetics (clinical white, minimal branding) or consumer-grade design (lifestyle colors, bold branding). Both routes are compliance-first.
Compliance Documentation
We compile FDA and CPSC-compliant packaging documentation directly. For NHS, MHRA, NIH, and EU cessation programs, we identify the required packaging-level certificates and align our documentation with your regulatory team's specifications.
View compliance documentationProduction
Full production with inline QC and batch-level traceability. Every unit is linked to a production lot for audit readiness.
Post-Market Support
Packaging-level regulatory updates, re-certification, and audit documentation support for the full program lifecycle. Documentation archived for 7 years.
Required Documentation by Market
What your regulatory team typically needs for tender submission. We compile the packaging-level documents directly; for program-specific registrations, we guide alignment.
🇺🇸US (FDA / CPSC)
- ISO 8317 CR Report
- FDA Food-Contact Statement
- CPSC 16 CFR 1700.20
- Batch Traceability Template
🇪🇺EU (TPD Art. 20)
- ISO 8317 CR Report
- Food-Contact Migration Test
- REACH SVHC Declaration
- Batch Traceability Template
- Health Warning Template
🇬🇧UK (MHRA)
- ISO 8317 CR Report
- UKCA Declaration
- MHRA Device Registration Guide
- Batch Traceability Template
- NHS Onboarding Checklist
🇦🇺Australia (TGA)
- ISO 8317 CR Report
- TGA GMP Alignment Letter
- Poison Schedule Compliance
- Batch Traceability Template
Proof You Can Verify
7 years
Batch documentation archived for regulatory audit traceability
100%
CR certification conformance rate across all shipped batches
10,000 pcs
Minimum pilot order for program trials and tender submissions
Case Study
"A leading EU pharmacy chain launched their NRT program in 6 weeks using our pre-formatted NHS documentation bundle."
From first inquiry to market entry — including ISO 8317 testing, MHRA registration alignment, and batch traceability setup.
See how we helped this client meet NHS requirementsPackaging-Level Documentation Support
FDA and CPSC packaging documentation is pre-formatted. For NHS, NIH, EU, and TGA markets, we identify requirements and align our packaging-level documentation with your regulatory team's specifications. Each alignment includes CR test reports, material safety data sheets, batch traceability templates, and compliance checklists — saving you 6–12 weeks of document preparation. Digital records archived for 7 years. Full traceability reports provided with every shipment.
Explore CR compliance solutionsFrequently asked questions
Do you provide packaging for NHS and government cessation programs?
What is the difference between recreational and cessation-program packaging?
Can you help with regulatory documentation for program approval?
What MOQ applies to cessation-program orders?
How do you handle batch traceability for medical programs?
Can the packaging design be adjusted for different program requirements?
What is NRT, and why does it need different packaging from recreational nicotine pouches?
Can you label packaging with specific mg-strengths like 2 mg, 11 mg, or 20 mg?
How long does documentation preparation take for a government tender?
Do you offer packaging for zero-nicotine or nicotine-free stop-smoking pouches?
Ready for Program Approval?
Request a compliance dossier with regulatory templates, CR certification previews, and a design guide tailored to your target cessation program.